The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease

Objective: This study aims to investigate the clinical value of serum Klotho and FGF23 in cardiac valve calcification in patients with chronic kidney disease (CKD). Methods: In the present study, 180 patients with CKD, who were admitted to the department of nephrology of our hospital on April 1, 201...

Full description

Saved in:
Bibliographic Details
Published in:International journal of general medicine 2021-03, Vol.14, p.857
Main Authors: Chen, Yan, Chen, Yan-Xia, Huang, Chong, Duan, Zhi-Bing, Xu, Cheng-Yun
Format: Article
Language:English
Subjects:
Albumin
Calcification
Chronic kidney failure
Development and progression
Heart valve diseases
Hemoglobin
Medical research
Medicine, Experimental
Risk factors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 857
container_title International journal of general medicine
container_volume 14
creator Chen, Yan
Chen, Yan-Xia
Huang, Chong
Duan, Zhi-Bing
Xu, Cheng-Yun
description Objective: This study aims to investigate the clinical value of serum Klotho and FGF23 in cardiac valve calcification in patients with chronic kidney disease (CKD). Methods: In the present study, 180 patients with CKD, who were admitted to the department of nephrology of our hospital on April 1, 2016 (solstice, 2019), were selected as the main subjects. According to the CKD stage, these patients were divided into three groups: CKD2-3 group, CKD4 group, and CKD5 group. In each group, ultrasound was used to evaluate the cardiac valve calcification, and the independent risk factors for cardiac valve calcification were analyzed by Logistic regression. Results: The levels of hemoglobin and blood calcium in CKD2-3 patients were higher than those in CKD4 and CKD5 patients, and the levels of hemoglobin and blood calcium in CKD5 patients were higher than those in CKD4 patients (P
doi_str_mv 10.2l47/IJGM.S299l97
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A658505057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A658505057</galeid><sourcerecordid>A658505057</sourcerecordid><originalsourceid>FETCH-LOGICAL-g677-ee1bac9a85db932be5f3c4d0da6397a8c13adac98ba6988c4c98a7928dc678de3</originalsourceid><addsrcrecordid>eNptjM1OwzAQhC0EEqVw4wFW4pySxIl_jlWgpbQIJCqu1cZ2GiPXRnUA8fYYwaEHNIedWX0zhFwW-aR0Fb9e3M8fJs-llE7yIzIqCi4ynvPq-MCfkrMYX_OcMVbQEXlb9wYaZ71V6OAF3buB0MHShaEPgF7DbD4rKVgPDe61RfUDfaQOOmW71Bps8DDdBb-FpxSMHyJ82qGHpt-HNAtLq735ghsbDUZzTk46dNFc_N0xWc9u181dtnqcL5rpKtsyzjNjihaVRFHrVtKyNXVHVaVzjYxKjkIVFHUCRItMCqGqZJHLUmjFuNCGjsnV7-wWndlY34Vhj2pno9pMWS3qPIknavIPlaTNzqrgTWfT_6DwDWHKay8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Chen, Yan ; Chen, Yan-Xia ; Huang, Chong ; Duan, Zhi-Bing ; Xu, Cheng-Yun</creator><creatorcontrib>Chen, Yan ; Chen, Yan-Xia ; Huang, Chong ; Duan, Zhi-Bing ; Xu, Cheng-Yun</creatorcontrib><description>Objective: This study aims to investigate the clinical value of serum Klotho and FGF23 in cardiac valve calcification in patients with chronic kidney disease (CKD). Methods: In the present study, 180 patients with CKD, who were admitted to the department of nephrology of our hospital on April 1, 2016 (solstice, 2019), were selected as the main subjects. According to the CKD stage, these patients were divided into three groups: CKD2-3 group, CKD4 group, and CKD5 group. In each group, ultrasound was used to evaluate the cardiac valve calcification, and the independent risk factors for cardiac valve calcification were analyzed by Logistic regression. Results: The levels of hemoglobin and blood calcium in CKD2-3 patients were higher than those in CKD4 and CKD5 patients, and the levels of hemoglobin and blood calcium in CKD5 patients were higher than those in CKD4 patients (P&lt;0.05). Albumin was lower in CKD2-3 patients when compared to CKD5 patients while albumin was higher in CKD5 patients when compared to CKD4 patients (P&lt;0.05). The serum levels of FGF23 was lower in CKD2-3 patients when compared to CKD4 and CKD5 patients while the serum levels of FGF23 was lower in CKD4 patients when compared to CKD5 patients (P&lt;0.05). The serum levels of Klotho was higher in CKD2-3 patients, when compared to CKD4 and CKD5 patients, while the serum levels of Klotho was higher in CKD4 patients, when compared to CKD5 patients (P&lt;0.05). The logistic regression analysis revealed that GFR, serum creatinine, FGF23 and Klotho were independent risk factors for cardiac valve calcification in patients with CKD. Conclusion: With the decrease of GFR in CKD patients, the serum levels of FGF23 increases, while the serum levels of Klotho decreases. Furthermore, the serum levels of FGF23 and Klotho are affected by various factors, and the levels of FGF23 and Klotho in CKD patients are negatively correlated. GFR, serum creatinine, FGF23 and Klotho are independent risk factors for heart valve calcification in patients with CKD. Keywords: Klotho, FGF23, chronic kidney disease, cardiac valve calcification, logistic regression analysis</description><identifier>ISSN: 1178-7074</identifier><identifier>EISSN: 1178-7074</identifier><identifier>DOI: 10.2l47/IJGM.S299l97</identifier><language>eng</language><publisher>Dove Medical Press Limited</publisher><subject>Albumin ; Calcification ; Chronic kidney failure ; Development and progression ; Heart valve diseases ; Hemoglobin ; Medical research ; Medicine, Experimental ; Risk factors</subject><ispartof>International journal of general medicine, 2021-03, Vol.14, p.857</ispartof><rights>COPYRIGHT 2021 Dove Medical Press Limited</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Chen, Yan</creatorcontrib><creatorcontrib>Chen, Yan-Xia</creatorcontrib><creatorcontrib>Huang, Chong</creatorcontrib><creatorcontrib>Duan, Zhi-Bing</creatorcontrib><creatorcontrib>Xu, Cheng-Yun</creatorcontrib><title>The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease</title><title>International journal of general medicine</title><description>Objective: This study aims to investigate the clinical value of serum Klotho and FGF23 in cardiac valve calcification in patients with chronic kidney disease (CKD). Methods: In the present study, 180 patients with CKD, who were admitted to the department of nephrology of our hospital on April 1, 2016 (solstice, 2019), were selected as the main subjects. According to the CKD stage, these patients were divided into three groups: CKD2-3 group, CKD4 group, and CKD5 group. In each group, ultrasound was used to evaluate the cardiac valve calcification, and the independent risk factors for cardiac valve calcification were analyzed by Logistic regression. Results: The levels of hemoglobin and blood calcium in CKD2-3 patients were higher than those in CKD4 and CKD5 patients, and the levels of hemoglobin and blood calcium in CKD5 patients were higher than those in CKD4 patients (P&lt;0.05). Albumin was lower in CKD2-3 patients when compared to CKD5 patients while albumin was higher in CKD5 patients when compared to CKD4 patients (P&lt;0.05). The serum levels of FGF23 was lower in CKD2-3 patients when compared to CKD4 and CKD5 patients while the serum levels of FGF23 was lower in CKD4 patients when compared to CKD5 patients (P&lt;0.05). The serum levels of Klotho was higher in CKD2-3 patients, when compared to CKD4 and CKD5 patients, while the serum levels of Klotho was higher in CKD4 patients, when compared to CKD5 patients (P&lt;0.05). The logistic regression analysis revealed that GFR, serum creatinine, FGF23 and Klotho were independent risk factors for cardiac valve calcification in patients with CKD. Conclusion: With the decrease of GFR in CKD patients, the serum levels of FGF23 increases, while the serum levels of Klotho decreases. Furthermore, the serum levels of FGF23 and Klotho are affected by various factors, and the levels of FGF23 and Klotho in CKD patients are negatively correlated. GFR, serum creatinine, FGF23 and Klotho are independent risk factors for heart valve calcification in patients with CKD. Keywords: Klotho, FGF23, chronic kidney disease, cardiac valve calcification, logistic regression analysis</description><subject>Albumin</subject><subject>Calcification</subject><subject>Chronic kidney failure</subject><subject>Development and progression</subject><subject>Heart valve diseases</subject><subject>Hemoglobin</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Risk factors</subject><issn>1178-7074</issn><issn>1178-7074</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjM1OwzAQhC0EEqVw4wFW4pySxIl_jlWgpbQIJCqu1cZ2GiPXRnUA8fYYwaEHNIedWX0zhFwW-aR0Fb9e3M8fJs-llE7yIzIqCi4ynvPq-MCfkrMYX_OcMVbQEXlb9wYaZ71V6OAF3buB0MHShaEPgF7DbD4rKVgPDe61RfUDfaQOOmW71Bps8DDdBb-FpxSMHyJ82qGHpt-HNAtLq735ghsbDUZzTk46dNFc_N0xWc9u181dtnqcL5rpKtsyzjNjihaVRFHrVtKyNXVHVaVzjYxKjkIVFHUCRItMCqGqZJHLUmjFuNCGjsnV7-wWndlY34Vhj2pno9pMWS3qPIknavIPlaTNzqrgTWfT_6DwDWHKay8</recordid><startdate>20210331</startdate><enddate>20210331</enddate><creator>Chen, Yan</creator><creator>Chen, Yan-Xia</creator><creator>Huang, Chong</creator><creator>Duan, Zhi-Bing</creator><creator>Xu, Cheng-Yun</creator><general>Dove Medical Press Limited</general><scope/></search><sort><creationdate>20210331</creationdate><title>The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease</title><author>Chen, Yan ; Chen, Yan-Xia ; Huang, Chong ; Duan, Zhi-Bing ; Xu, Cheng-Yun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g677-ee1bac9a85db932be5f3c4d0da6397a8c13adac98ba6988c4c98a7928dc678de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Albumin</topic><topic>Calcification</topic><topic>Chronic kidney failure</topic><topic>Development and progression</topic><topic>Heart valve diseases</topic><topic>Hemoglobin</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Yan</creatorcontrib><creatorcontrib>Chen, Yan-Xia</creatorcontrib><creatorcontrib>Huang, Chong</creatorcontrib><creatorcontrib>Duan, Zhi-Bing</creatorcontrib><creatorcontrib>Xu, Cheng-Yun</creatorcontrib><jtitle>International journal of general medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Yan</au><au>Chen, Yan-Xia</au><au>Huang, Chong</au><au>Duan, Zhi-Bing</au><au>Xu, Cheng-Yun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease</atitle><jtitle>International journal of general medicine</jtitle><date>2021-03-31</date><risdate>2021</risdate><volume>14</volume><spage>857</spage><pages>857-</pages><issn>1178-7074</issn><eissn>1178-7074</eissn><abstract>Objective: This study aims to investigate the clinical value of serum Klotho and FGF23 in cardiac valve calcification in patients with chronic kidney disease (CKD). Methods: In the present study, 180 patients with CKD, who were admitted to the department of nephrology of our hospital on April 1, 2016 (solstice, 2019), were selected as the main subjects. According to the CKD stage, these patients were divided into three groups: CKD2-3 group, CKD4 group, and CKD5 group. In each group, ultrasound was used to evaluate the cardiac valve calcification, and the independent risk factors for cardiac valve calcification were analyzed by Logistic regression. Results: The levels of hemoglobin and blood calcium in CKD2-3 patients were higher than those in CKD4 and CKD5 patients, and the levels of hemoglobin and blood calcium in CKD5 patients were higher than those in CKD4 patients (P&lt;0.05). Albumin was lower in CKD2-3 patients when compared to CKD5 patients while albumin was higher in CKD5 patients when compared to CKD4 patients (P&lt;0.05). The serum levels of FGF23 was lower in CKD2-3 patients when compared to CKD4 and CKD5 patients while the serum levels of FGF23 was lower in CKD4 patients when compared to CKD5 patients (P&lt;0.05). The serum levels of Klotho was higher in CKD2-3 patients, when compared to CKD4 and CKD5 patients, while the serum levels of Klotho was higher in CKD4 patients, when compared to CKD5 patients (P&lt;0.05). The logistic regression analysis revealed that GFR, serum creatinine, FGF23 and Klotho were independent risk factors for cardiac valve calcification in patients with CKD. Conclusion: With the decrease of GFR in CKD patients, the serum levels of FGF23 increases, while the serum levels of Klotho decreases. Furthermore, the serum levels of FGF23 and Klotho are affected by various factors, and the levels of FGF23 and Klotho in CKD patients are negatively correlated. GFR, serum creatinine, FGF23 and Klotho are independent risk factors for heart valve calcification in patients with CKD. Keywords: Klotho, FGF23, chronic kidney disease, cardiac valve calcification, logistic regression analysis</abstract><pub>Dove Medical Press Limited</pub><doi>10.2l47/IJGM.S299l97</doi></addata></record>
fulltext fulltext
identifier ISSN: 1178-7074
ispartof International journal of general medicine, 2021-03, Vol.14, p.857
issn 1178-7074
1178-7074
language eng
recordid cdi_gale_infotracmisc_A658505057
source Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central
subjects Albumin
Calcification
Chronic kidney failure
Development and progression
Heart valve diseases
Hemoglobin
Medical research
Medicine, Experimental
Risk factors
title The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A13%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Clinical%20Value%20of%20Klotho%20and%20FGF23%20in%20Cardiac%20Valve%20Calcification%20Among%20Patients%20with%20Chronic%20Kidney%20Disease&rft.jtitle=International%20journal%20of%20general%20medicine&rft.au=Chen,%20Yan&rft.date=2021-03-31&rft.volume=14&rft.spage=857&rft.pages=857-&rft.issn=1178-7074&rft.eissn=1178-7074&rft_id=info:doi/10.2l47/IJGM.S299l97&rft_dat=%3Cgale%3EA658505057%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g677-ee1bac9a85db932be5f3c4d0da6397a8c13adac98ba6988c4c98a7928dc678de3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A658505057&rfr_iscdi=true